The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Ancestry-adjusted genomic analysis to identify known and novel associations with single and multiple cancer phenotypes.
 
Vijai Joseph
Patents, Royalties, Other Intellectual Property - Title: DIAGNOSIS & TREATMENT OF ERCC3-MUTANT CANCER Inventors: Vijai Joseph, Sabine Topka, Kenneth Offit US National Stage Patent Application No.: 16/493,214 Filing Date: September 11, 2019 (Inst)
 
Vignesh Ravichandran
No Relationships to Disclose
 
Irina Ostrovnaya
No Relationships to Disclose
 
Ying L Liu
Research Funding - AstraZeneca (Inst); Repare Therapeutics (Inst); Tesaro/GSK (Inst)
Travel, Accommodations, Expenses - AstraZeneca
 
Kaitlyn Tkachuk
No Relationships to Disclose
 
Aliya Khurram
No Relationships to Disclose
 
Yelena Kemel
No Relationships to Disclose
 
Diana Mandelker
No Relationships to Disclose
 
Chaitanya Bandlamudi
No Relationships to Disclose
 
Michael Francis Walsh
No Relationships to Disclose
 
Michael T Conry
No Relationships to Disclose
 
Aijazuddin Syed
No Relationships to Disclose
 
Nikolaus Schultz
No Relationships to Disclose
 
David B. Solit
Stock and Other Ownership Interests - Fore Biotherapeutics; Pyramid Biosciences; Scorpion Therapeutics; Vividion Therapeutics
Consulting or Advisory Role - BridgeBio Pharma; Fog Therapeutics; Fore Biotherapeutics; Pfizer; Scorpion Therapeutics; Vividion Therapeutics
 
Michael F. Berger
Consulting or Advisory Role - AstraZeneca; Lilly; PetDx
Patents, Royalties, Other Intellectual Property - Provisional patent pending for "Systems and Methods for Detecting Cancer via cfDNA Screening"
 
Mark E. Robson
Consulting or Advisory Role - Change HealthCare
Research Funding - AstraZeneca (Inst); Merck (Inst); Pfizer (Inst); Zenith Pharmaceuticals (Inst)
Other Relationship - AstraZeneca; Clinical Care Options; Clinical Education Alliance; MJH Healthcare Holdings, LLC; MyMedEd; Pfizer; Physicans' Education Resource; Research to Practice
(OPTIONAL) Uncompensated Relationships - Artios; Daiichi Sankyo; Epic Sciences; Merck; Pfizer; Tempus; Zenith Pharmaceuticals
 
Zsofia Kinga Stadler
Consulting or Advisory Role - Adverum (I); Genentech/Roche (I); Gyroscope (I); Neurogene (I); Optos (I); Outlook Therapeutics (I); Regeneron (I); Regenxbio (I)
 
Kenneth Offit
Patents, Royalties, Other Intellectual Property - Patent pending on therapeutic applications of targeting ERCC3 mutations in cancer. Diagnosis & treatment of ercc3-mutant cancer US20210137850A1
Other Relationship - AnaNeo Therapeutics